» Articles » PMID: 27194319

System-level and Patient-level Explanations for Non-attendance at Diabetic Retinopathy Screening in Sutton and Merton (London, UK): a Qualitative Analysis of a Service Evaluation

Overview
Journal BMJ Open
Specialty General Medicine
Date 2016 May 20
PMID 27194319
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Non-attendance at diabetic retinopathy screening has financial implications for screening programmes and potential clinical costs to patients. We sought to identify explanations for why patients had never attended a screening appointment (never attendance) in one programme.

Design: Qualitative analysis of a service evaluation.

Setting: One South London (UK) diabetic eye screening programme.

Participants And Procedure: Patients who had been registered with one screening programme for at least 18 months and who had never attended screening within the programme were contacted by telephone to ascertain why this was the case. Patients' general practices were also contacted for information about why each patient may not have attended. Framework analysis was used to interpret responses.

Results: Of the 296 patients, 38 were not eligible for screening and of the 258 eligible patients, 159 were not contactable (31 of these had phone numbers that were not in use). We obtained reasons from patients/general practices/clinical notes for non-attendance for 146 (57%) patients. A number of patient-level and system-level factors were given to explain non-attendance. Patient-level factors included having other commitments, being anxious about screening, not engaging with any diabetes care and being misinformed about screening. System-level factors included miscommunication about where the patient lives, their clinical situation and practical problems that could have been overcome had their existence been shared between programmes.

Conclusions: This service evaluation provides unique insight into the patient-level and system-level reasons for never attendance at diabetic retinopathy screening. Improved sharing of relevant information between providers has the potential to facilitate increased uptake of screening. Greater awareness of patient-level barriers may help providers offer a more accessible service.

Citing Articles

Barriers and enablers of access to diabetes eye care in Auckland, New Zealand: a qualitative study.

Silwal P, Pirouzi M, Murphy R, Harwood M, Grey C, Squirrell D BMJ Open. 2025; 15(1):e087650.

PMID: 39890153 PMC: 11784328. DOI: 10.1136/bmjopen-2024-087650.


A qualitative study to understand the barriers and enablers of access to diabetic screening services in Nigeria.

Ozioko N, Kamalakannan S Int J Community Med Public Health. 2024; 11(9):3642-3650.

PMID: 39380767 PMC: 7616678. DOI: 10.18203/2394-6040.ijcmph20242571.


Evaluating Adherence to Diabetic Retinopathy Care in an Urban Ophthalmology Clinic Utilizing the Compliance With Annual Diabetic Eye Exams Survey.

Davis T, Luo F, Xie S, Muro-Fuentes E, Rodrigues E Cureus. 2023; 15(1):e34083.

PMID: 36843721 PMC: 9946894. DOI: 10.7759/cureus.34083.


The Effect on Patients' Visual Acuity and Grade, Secondary to Non-Attendance at Treatment Centers, Post Referral from Diabetic RetinaScreen Ireland.

Harmon J, Kelly S, Acheson R, Keegan D, McMahon S, Kavanagh H Clin Ophthalmol. 2023; 17:183-190.

PMID: 36660306 PMC: 9843507. DOI: 10.2147/OPTH.S388988.


Mental health support across the sight loss pathway: a qualitative exploration of eye care patients, optometrists, and ECLOs.

Trott M, Driscoll R, Bourne R, Slade J, Ingleton H, Farrell S Eye (Lond). 2023; 37(12):2554-2558.

PMID: 36627444 PMC: 10397192. DOI: 10.1038/s41433-022-02373-z.


References
1.
Danaei G, Finucane M, Lu Y, Singh G, Cowan M, Paciorek C . National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011; 378(9785):31-40. DOI: 10.1016/S0140-6736(11)60679-X. View

2.
Waqar S, Bullen G, Chant S, Salman R, Vaidya B, Ling R . Cost implications, deprivation and geodemographic segmentation analysis of non-attenders (DNA) in an established diabetic retinopathy screening programme. Diabetes Metab Syndr. 2012; 6(4):199-202. DOI: 10.1016/j.dsx.2012.08.009. View

3.
Forster A, Forbes A, Dodhia H, Connor C, du Chemin A, Sivaprasad S . Non-attendance at diabetic eye screening and risk of sight-threatening diabetic retinopathy: a population-based cohort study. Diabetologia. 2013; 56(10):2187-93. DOI: 10.1007/s00125-013-2975-0. View

4.
Lewis K, Patel D, Yorston D, Charteris D . A qualitative study in the United Kingdom of factors influencing attendance by patients with diabetes at ophthalmic outpatient clinics. Ophthalmic Epidemiol. 2007; 14(6):375-80. DOI: 10.1080/09286580701375195. View

5.
Maberley D, Koushik A, Cruess A . Factors associated with missed eye examinations in a cohort with diabetes. Can J Public Health. 2002; 93(3):229-32. PMC: 6979876. View